PAD 0106
Pill imprint PAD 0106 has been identified as Bromocriptine mesylate 2.5 mg.
Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; acromegaly; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy.
Bromocriptine 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Bromocriptine mesylate Images
- Imprint:
-
PAD 0106
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
magnesium stearate
maleic acid
povidone
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Paddock Laboratories, Inc.
- National Drug Code (NDC):
- 00574-0106
Advertisement
More Bromocriptine Mesylate resources
- Bromocriptine (Wolters Kluwer)
- Bromocriptine Mesylate (Wolters Kluwer)
- bromocriptine (Cerner Multum)
- bromocriptine (Micromedex) - Includes Dosage Information
- Bromocriptine Mesylate (AHFS DI)
- Bromocriptine (FDA)
- Bromocriptine Capsules (FDA)
- Bromocriptine Mesylate (Wolters Kluwer)
Search Again
